Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
IUBMB Life ; 62(9): 688-92, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20836127

RESUMO

DJ-1 is a mitochondrial protein linked to Parkinson's disease. DJ-1 has been suggested to have several possible functions, although it has been mainly associated to oxidative stress defence. Changes in the two-dimensional electrophoresis pattern have been thoroughly described as a consequence of oxidative modification of the Cys106 residue. There is accumulating evidence supporting a specific role of DJ-1 in protecting dopaminergic neurons from dopamine itself. By exposing SH-SY5Y human neuroblastoma catecholaminergic cells to dopamine, we observed a specific increase in the most acidic forms in the DJ-1 two-dimensional electrophoresis pattern together with a significant decrease of the most basic spot. Unlike cells exposed to generic oxidative conditions, no additional shift was observed. The results are corroborated by a meta-analysis of the literature showing that in the absence of dopamine treatment the specific acidic form is underrepresented.


Assuntos
Dopamina/farmacologia , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Neuroblastoma/metabolismo , Proteínas Oncogênicas/metabolismo , Doença de Parkinson , Western Blotting , Linhagem Celular Tumoral , Dopaminérgicos/farmacologia , Eletroforese em Gel Bidimensional , Citometria de Fluxo , Humanos , Proteína Desglicase DJ-1 , Isoformas de Proteínas/efeitos dos fármacos , Isoformas de Proteínas/metabolismo
2.
Parkinsonism Relat Disord ; 14 Suppl 2: S135-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18585082

RESUMO

Dopaminergic neurons are particularly exposed to oxidative stress because dopamine metabolism gives rise to endogenous toxins. Here, two different models for dopamine toxicity have been investigated using proteomics: stable alpha-synuclein-expressing neuroblastoma (SH-SY5Y) cells to understand how alpha-synuclein modulates dopamine toxicity at the central level, and cultured T-cell leukaemia (Jurkat) cells challenged with dopamine or l-dopa to evaluate protein changes on the surface of peripheral cells. alpha-synuclein-expressing cells were more resistant compared with wild-type cells, showing upregulation of antioxidant proteins including the Parkinson's disease-related DJ-1 protein. In addition, treatment of prototypical T-cells with l-dopa induced significant changes in proteins on the cell surface, indicating that peripheral blood lymphocytes may be good indicators of dopamine toxicity.


Assuntos
Dopamina/toxicidade , Síndromes Neurotóxicas , Proteômica/métodos , Animais , Linhagem Celular Tumoral , Humanos , Neuroblastoma/patologia , Síndromes Neurotóxicas/etiologia , Síndromes Neurotóxicas/metabolismo , Síndromes Neurotóxicas/patologia
3.
Biochem Biophys Res Commun ; 349(4): 1294-300, 2006 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-16978583

RESUMO

Dopaminergic human neuroblastoma SH-SY5Y cells were stably transformed to increase expression of alpha-synuclein, a Parkinson's disease-related protein. Transformed cells were more resistant to oxidative insults, showing a cytoprotective role of alpha-synuclein. The expression of redox chaperonins (DJ-1, HSP70, and 14-3-3) was evaluated by Western blotting. Expression of alpha-synuclein reduced HSP70 levels even in the presence of dopamine, with a twofold increase of DJ-1 in the absence of oxidants. DJ-1 is significantly reduced by dopamine, and even more by dopamine and Cu(II). Increased alpha-synuclein expression did not affect 14-3-3, although dopamine increased its level by 60% in wild-type cells. alpha-Synuclein not only upregulated DJ-1, but also shifted all DJ-1 forms to a single spot at pI=5.7 not observed in wild-type cells. Dopamine gradually restored the distribution of DJ-1 forms to a situation similar to wild-type cells, with the form at pI=6.1 progressively enriched under oxidative conditions.


Assuntos
Apoptose/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Dopamina/administração & dosagem , Neuroblastoma/patologia , alfa-Sinucleína/administração & dosagem , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA